Explore more publications!

Asia Business Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.

Press releases published on December 2, 2025

Primech A & P Named Industry Star Award Top 10 Winner 2025
Power Semiconductor Market Expected to Reach $75.1 Billion by 2032
LCR Capital Partners Announces First I-526 Approvals for Thompson Palm Springs EB-5 Investors
Semiconductor Foundry Market Expected to Reach $231.5 Billion by 2032
Flower Turbines Announces Solutions for Data Center Energy
Perseus Mining Delivers Superior Proposal for Predictive Discovery
Success in NAPLAN Takes Patience: AVID Australia Celebrates Progress and Looks to the Future
Moomoo 與 OTC Markets 的 MOON ATS® 合作,擴展其為零售投資者而設的 24 小時交易服務
Moomoo Bekerjasama dengan MOON ATS® Milik OTC Markets untuk Meluaskan Dagangan 24 Jam bagi Pelabur Runcit
DXCM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
The Magnificent Mile Holiday Shopping Week Debuts December 6–14
CPTN DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Cepton, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CPTN
Latest Report: Chemical Technology Market Predicted to Showcase Striking Growth at a CAGR of 6.2% by 2031
Clene to Provide CNM-Au8® ALS Program Update
Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines
Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines
ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Openxcell Delivers Measurable AI Results in 2025, Setting New Standards for Enterprise Transformation in 2026

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions